<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket9416</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-9416</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Патогенные иерсинии и болезнь Грейвса</article-title><trans-title-group xml:lang="en"><trans-title>Yersinia infections and Graves’ disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6296-898X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хамнуева</surname><given-names>Лариса Юрьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Khamnueva</surname><given-names>Larissa Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, заведующая кафедрой эндокринологии и клинической фармакологии</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">hamnueval@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3441-3498</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гома</surname><given-names>Татьяна Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Goma</surname><given-names>Tatyana V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, ассистент, кафедра факультетской терапии</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">tanyagoma@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0036-0017</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Климов</surname><given-names>Валерий Тимофеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Klimov</surname><given-names>Valery T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, старший научный сотрудник</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">41klimov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБОУ ВО Иркутский государственный медицинский университет Минздрава России&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Irkutsk State Medical University&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>&lt;p&gt;ФКУЗ Иркутский ордена Трудового Красного Знамени научно-исследовательский противочумный институт Сибири и Дальнего Востока Роспотребнадзора&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Irkutsk Plague Control Research Institute of Siberia and Far East&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>06</day><month>06</month><year>2018</year></pub-date><volume>14</volume><issue>1</issue><fpage>11</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хамнуева Л.Ю., Гома Т.В., Климов В.Т., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Хамнуева Л.Ю., Гома Т.В., Климов В.Т.</copyright-holder><copyright-holder xml:lang="en">Khamnueva L.Y., Goma T.V., Klimov V.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/9416">https://www.cet-endojournals.ru/jour/article/view/9416</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Наиболее часто встречающимся заболеванием щитовидной железы, сопровождающимся синдромом тиреотоксикоза, является болезнь Грейвса (БГ). Сведения о роли иерсиний в развитии данного заболевания противоречивы.</p></sec><sec><title>Цель</title><p>Цель. Определить значение Yersinia enterocolitica и Y. pseudotuberculоsis в развитии БГ.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 78 больных БГ. Выявление антител к иерсиниям проводилось следующими методами: 1) реакцией агглютинации (РА) с суспензиями живых вирулентных бактерий Y. pseudotuberculosis, Y. enterocolitica О:3 и О:9; 2) реакцией непрямой гемагглютинации (РНГА) с применением эритроцитарного диагностикума; 3) определением антител классов IgA и IgG к белкам «патогенности» штаммов иерсиний методом иммуноблотинга (30 больных).</p></sec><sec><title>Результаты</title><p>Результаты. У всех больных БГ получены диагностически значимые титры антител в РА. В группе пациентов с максимальным титром антител обнаружен наибольший общий объем щитовидной железы по данным УЗИ (р = 0,010) и максимальная длительность течения заболевания (р = 0,040). Не обнаружено связей между титром антител к иерсиниям и уровнями тиреоидных гормонов, стимулирующих антител к рецептору тиреотропного гормона. У 30 больных БГ (9 пациентов с титром антител в РА 1:800–1:1600, 17 – 1:400, 4 – 1:200) тест на выявление антител класса IgA был отрицательный. У всех пациентов с максимальным титром антител в РА обнаружены положительные антитела IgG к антигенам YopM (Yop2a), YopH (Yop2b), V-антиген, YopD. Длительность течения БГ у пациентов с отрицательным титром антител в реакции иммуноблотинга была меньше, чем с положительным (р = 0,010). Отсутствие активной и/или перенесенной иерсиниозной инфекции у всех обследованных больных БГ подтвердили отрицательные клинико-анамнестические данные и негативные результаты исследования сывороток в РНГА.</p></sec><sec><title>Заключение</title><p>Заключение. В сыворотке крови больных БГ в РА и методом иммуноблотинга определяются перекрестно-реагирующие антитела к антигенам Y. enterocolitica. Диагностический титр данных антител чаще выявляется у пациентов с большей длительностью БГ, значительным объемом щитовидной железы. Отсутствие связи между титром данных антител и уровнями тиреоидных гормонов, антител к рецептору тиреотропного гормона, а также негативные результаты в РНГА с диагностикумом, не содержащим белков наружной мембраны патогенных иерсиний, отрицают триггерную роль иерсиниозной инфекции как инициирующего фактора развития БГ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. The most common thyroid disease, accompanied by thyrotoxicosis syndrome, is Graves&amp;apos; disease (GD). Information about the role of Yersinia in the development of this disease is contradictory.</p></sec><sec><title>Aims</title><p>Aims. To study the significance of Yersinia (Y.) enterocolitica and Y. pseudotuberculosis in the development of Graves&amp;apos; disease.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 78 patients with GD. Identification of antibodies to Y. was carried out by the following methods: 1. agglutination test (AT) with suspensions of live virulent cultures Y. pseudotuberculosis, Y. enterocolitica O:3 and O:9; 2. indirect hemagglutination test (IHET) with the use of erythrocyte diagnosticum; 3. determination of IgA and IgG antibodies against pathogenicity factors of Y. enterocolitica strains by immunoblotting (30 patients with GD).</p></sec><sec><title>Results</title><p>Results. Diagnostically significant titers of antibodies to Y. pseudotuberculosis and Y. enterocolitica were obtained in all patients with GD by AT. The greatest total thyroid volume determined by ultrasound investigation (p = 0.010) and the maximum duration of the disease (p = 0.040) were determined in the group of patients with the maximum antibody titer. No significant relation was found between the titer of antibodies to Yersinia and the levels of thyroid hormones stimulating the thyroid antibodies.The test for detection of IgA antibodies by immunoblotting was negative in 30 patients with GD (9 patients with a titer of antibodies by AT 1:800 – 1:1600, 17 – 1:400, 4 – 1:200). In all cases with the maximum antibody titer in AT, the positive IgG antibodies to the antigens YopM (Yop2a), YopH (Yop2b), V-antigen, YopD were found. The GD duration in patients with negative titers of antibodies by the immunoblotting test was less than with the positive one (p = 0.010). The privative clinical and anamnestic data and negative results by IHET confirmed the absence of active and/or transferred Yersinia infections in all the examined patients with GD.</p></sec><sec><title>Conclusions</title><p>Conclusions. The cross-reacting antibodies to the antigens of Y. enterocolitica are determined in the serum of GD patients by AT and immunoblotting. The diagnostic titer of these antibodies is more often detected in patients with greater GD duration and larger volume of the thyroid gland. The absence of a link between the titer of these antibodies and the levels of thyroid hormones, the antibodies to the thyrotropin receptors of pituitary, as well as negative results by IHET with a diagnosticum that does not contain outer membrane proteins of pathogenic Yersinia, deny the trigger role of Yersinia infections as an initiating factor in the development of GD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>иерсинии</kwd><kwd>болезнь Грейвса</kwd><kwd>перекрестная реактивность</kwd><kwd>антитела</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Yersinia infections</kwd><kwd>Graves’ disease</kwd><kwd>cross reaction</kwd><kwd>antibodies</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа проведена при поддержке ФГБОУ ВО Иркутский государственный медицинский университет Минздрава России, ФКГУЗ Иркутский ордена Трудового Красного Знамени научно-исследовательский противочумный институт Сибири и Дальнего Востока Роспотребнадзора в рамках совместной научной работы.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кроненберг Г.М., Мелмед Ш., Полонски К.С., Ларсен П.Р. Заболевания щитовидной железы. / Под ред. Дедова И.И., Мельниченко Г.А. – М.: ООО “Рид Элсивер”; 2010. [Kronenberg GM, Melmed S, Polonski KS, Larsen PR. Dedov II, Melnichenko GA, editors. Zabolevaniyashchitovidnoi zhelezy. Moscow: Reed Elsevier; 2010. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Кроненберг Г.М., Мелмед Ш., Полонски К.С., Ларсен П.Р. Заболевания щитовидной железы. / Под ред. Дедова И.И., Мельниченко Г.А. – М.: ООО “Рид Элсивер”; 2010. [Kronenberg GM, Melmed S, Polonski KS, Larsen PR. Dedov II, Melnichenko GA, editors. Zabolevaniyashchitovidnoi zhelezy. Moscow: Reed Elsevier; 2010. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bech K, Hannover Larsen J, Mlholm Hansen J, Nerup J. Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974; 304(7886):951-952. doi: 10.1016/s0140-6736(74)91152-0.</mixed-citation><mixed-citation xml:lang="en">Bech K, Hannover Larsen J, Mlholm Hansen J, Nerup J. Yersinia enterocolitica infection and thyroid disorders. Lancet. 1974; 304(7886):951-952. doi: 10.1016/s0140-6736(74)91152-0.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss M, Rubinstein E, Bottone EJ, et al. Yersinia enterocolitica antibodies in thyroid disorders. Isr J Med Sci. 1979;15(7):553-555.</mixed-citation><mixed-citation xml:lang="en">Weiss M, Rubinstein E, Bottone EJ, et al. Yersinia enterocolitica antibodies in thyroid disorders. Isr J Med Sci. 1979;15(7):553-555.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wenzel BE, Peters A, Zubaschev I. Bacterial virulence antigens and the pathogenesis of autoimmune thyroid diseases (AITD). Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:75-78. doi: 10.1055/s-0029-1211707.</mixed-citation><mixed-citation xml:lang="en">Wenzel BE, Peters A, Zubaschev I. Bacterial virulence antigens and the pathogenesis of autoimmune thyroid diseases (AITD). Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:75-78. doi: 10.1055/s-0029-1211707.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Takuno H, Sakata S, Miura K. Antibodies to Yersinia enterocolitica serotype 3 in autoimmune thyroid diseases. Endocrinol Jpn. 1990;37(4):489-500. doi: 10.1507/endocrj1954.37.489.</mixed-citation><mixed-citation xml:lang="en">Takuno H, Sakata S, Miura K. Antibodies to Yersinia enterocolitica serotype 3 in autoimmune thyroid diseases. Endocrinol Jpn. 1990;37(4):489-500. doi: 10.1507/endocrj1954.37.489.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gangi E, Kapatral V, El-Azami El-Idrissi M, et al. Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor. Autoimmunity. 2004;37(6-7):515-520. doi: 10.1080/08916930410001728074.</mixed-citation><mixed-citation xml:lang="en">Gangi E, Kapatral V, El-Azami El-Idrissi M, et al. Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor. Autoimmunity. 2004;37(6-7):515-520. doi: 10.1080/08916930410001728074.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Guarneri F, Carlotta D, Saraceno G, et al. Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid. 2011;21(11):1283-1284. doi: 10.1089/thy.2010.036.</mixed-citation><mixed-citation xml:lang="en">Guarneri F, Carlotta D, Saraceno G, et al. Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid. 2011;21(11):1283-1284. doi: 10.1089/thy.2010.036.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Zhang Q, Lu J, et al. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves&amp;apos; disease and determination of its epitope using mass spectrometry and bioinformatics tools. J Clin EndocrinolMetab. 2010;95(8):4012-4020. doi: 10.1210/jc.2009-2184.</mixed-citation><mixed-citation xml:lang="en">Wang Z, Zhang Q, Lu J, et al. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves&amp;apos; disease and determination of its epitope using mass spectrometry and bioinformatics tools. J Clin EndocrinolMetab. 2010;95(8):4012-4020. doi: 10.1210/jc.2009-2184.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rastawicki W. Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens. Med Dosw Mikrobiol. 2008;60(1):27-37.</mixed-citation><mixed-citation xml:lang="en">Rastawicki W. Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens. Med Dosw Mikrobiol. 2008;60(1):27-37.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hargreaves CE, Grasso M, Hampe CS, et al. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves&amp;apos; disease. J Immunol. 2013;190(11):5373-5381. doi: 10.4049/jimmunol.1203412.</mixed-citation><mixed-citation xml:lang="en">Hargreaves CE, Grasso M, Hampe CS, et al. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves&amp;apos; disease. J Immunol. 2013;190(11):5373-5381. doi: 10.4049/jimmunol.1203412.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gimenez-Barcons M, Colobran R, Gomez-Pau A, et al. Graves&amp;apos; disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation? J Immunol. 2015;194(9):4199-4206. doi: 10.4049/jimmunol.1500183.</mixed-citation><mixed-citation xml:lang="en">Gimenez-Barcons M, Colobran R, Gomez-Pau A, et al. Graves&amp;apos; disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation? J Immunol. 2015;194(9):4199-4206. doi: 10.4049/jimmunol.1500183.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Volpé R. Antibodies to plasmdo-encoated proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet. 1988;331(8586):647. doi: 10.1016/s0140-6736(88)91444-4.</mixed-citation><mixed-citation xml:lang="en">Volpé R. Antibodies to plasmdo-encoated proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet. 1988;331(8586):647. doi: 10.1016/s0140-6736(88)91444-4.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Asari S, Amino N, Horikawa M, Miyai K. Incidences of antibodies to Yersinia enterocolitica: High incidence of serotype O5 in autoimmune thyroid diseases in Japan. Endocrinol Jpn. 1989;36(3): 381-386. doi: 10.1507/endocrj1954.36.381.</mixed-citation><mixed-citation xml:lang="en">Asari S, Amino N, Horikawa M, Miyai K. Incidences of antibodies to Yersinia enterocolitica: High incidence of serotype O5 in autoimmune thyroid diseases in Japan. Endocrinol Jpn. 1989;36(3): 381-386. doi: 10.1507/endocrj1954.36.381.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., и др. Клинические рекомендации по диагностике и лечению тиреотоксикоза с диффузным зобом (диффузный токсический зоб, болезнь Грейвса-Базедова), узловым/многоузловым зобом. – М.; 2014. [Troshina EA, Sviridenko NY, Vanushko VE, et al. Klinicheskie rekomendatsii po diagnostike i lecheniyu tireotoksikoza s diffuznym zobom (diffuznyi toksicheskii zob, bolezn&amp;apos; Greivsa-Bazedova), uzlovym/mnogouzlovym zobom. Moscow; 2014. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., и др. Клинические рекомендации по диагностике и лечению тиреотоксикоза с диффузным зобом (диффузный токсический зоб, болезнь Грейвса-Базедова), узловым/многоузловым зобом. – М.; 2014. [Troshina EA, Sviridenko NY, Vanushko VE, et al. Klinicheskie rekomendatsii po diagnostike i lecheniyu tireotoksikoza s diffuznym zobom (diffuznyi toksicheskii zob, bolezn&amp;apos; Greivsa-Bazedova), uzlovym/mnogouzlovym zobom. Moscow; 2014. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Хамнуева Л.Ю., Сизых Т.П., Климов В.Т., Харитончик О.А. Состояние щитовидной железы при псевдотуберкулезе. // Сибирский медицинский журнал (Иркутск). – 1999. – Т. 18. – №3. – С. 32–35. [Khamnueva LY, Sizykh TP, Klimov VT, Kharitonchik OA. Thyroid condition in pseudotuberculesis. Sibirskii meditsinskii zhurnal (Irkutsk, Russia). 1999;18(3):32-35. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Хамнуева Л.Ю., Сизых Т.П., Климов В.Т., Харитончик О.А. Состояние щитовидной железы при псевдотуберкулезе. // Сибирский медицинский журнал (Иркутск). – 1999. – Т. 18. – №3. – С. 32–35. [Khamnueva LY, Sizykh TP, Klimov VT, Kharitonchik OA. Thyroid condition in pseudotuberculesis. Sibirskii meditsinskii zhurnal (Irkutsk, Russia). 1999;18(3):32-35. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Effraimidis G, Tijssen JG, Strieder TG, Wiersinga WM. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol. 2011;165(1):38-43. doi: 10.1111/j.1365-2249.2011.04399.x.</mixed-citation><mixed-citation xml:lang="en">Effraimidis G, Tijssen JG, Strieder TG, Wiersinga WM. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol. 2011;165(1):38-43. doi: 10.1111/j.1365-2249.2011.04399.x.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Серов В.В., Зайратьянц О.В. Аутоиммунизация и аутоиммунные болезни. // Архив патологии. – 1992. – Т. 54. – №3. – С. 5–12. [Serov VV, Zairat&amp;apos;yants OV. Autoimmunizatsiya i autoimmunnye bolezni. Arkh Patol. 1992;54(3):5-12. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Серов В.В., Зайратьянц О.В. Аутоиммунизация и аутоиммунные болезни. // Архив патологии. – 1992. – Т. 54. – №3. – С. 5–12. [Serov VV, Zairat&amp;apos;yants OV. Autoimmunizatsiya i autoimmunnye bolezni. Arkh Patol. 1992;54(3):5-12. (In Russ.)]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
